• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Immunoglobulin superfamily member 11 (IGSF11), Truncated

ACP17277

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP17277 Target NameIGSF11
FormLyophilized powderExpression SystemCustom Production. Please inquire and provide the desire expression system.
Protein LengthPartialPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ5DX21
Background Information
  • Uniprot Id

    Q5DX21

  • Target Species

    Human

  • Target Name

    IGSF11

  • Target Full Name

    Immunoglobulin superfamily member 11

  • Target Function

    Functions as a cell adhesion molecule through homophilic interaction. Stimulates cell growth.

  • Target Subcellular Location

    Cell membrane; Single-pass type I membrane protein.

  • Target Tissue Specificity

    Abundantly expressed in testis and ovary and to a lower extent in brain, kidney and skeletal muscle.

  • Target Synonyms

    IGSF11; BTIGSF; CXADRL1; VSIG3; Immunoglobulin superfamily member 11; IgSF11; Brain and testis-specific immunoglobulin superfamily protein; Bt-IGSF; V-set and immunoglobulin domain-containing protein 3

  • Target Background

    IGSF11 is an immunoglobulin (Ig) superfamily member that is preferentially expressed in brain and testis. It shares significant homology with coxsackievirus and adenovirus receptor (CXADR; MIM 602621) and endothelial cell-selective adhesion molecule (ESAM).

Inquire Recombinant Human Immunoglobulin superfamily member 11 (IGSF11), Truncated Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification